Zhongfang Wang Selected Research

Granzymes (Granzyme)

11/2018	MAIT cells contribute to protection against lethal influenza infection in vivo.
1/2016	Human mucosal-associated invariant T cells contribute to antiviral influenza immunity via IL-18-dependent activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhongfang Wang Research Topics

Disease

20	Infections 03/2024 - 02/2010
12	Human Influenza (Influenza) 11/2022 - 01/2014
9	COVID-19 03/2024 - 05/2020
5	Virus Diseases (Viral Diseases) 01/2021 - 01/2016
2	Severe Acute Respiratory Syndrome 04/2024 - 01/2023
2	Breakthrough Infections 12/2023 - 12/2022
2	Cytokine Release Syndrome 10/2022 - 01/2014
1	Reinfection 12/2023
1	Lung Injury 10/2022
1	Communicable Diseases (Infectious Diseases) 04/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Tularemia 01/2022
1	Hyperplasia 04/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 05/2020
1	Dyspnea (Shortness of Breath) 05/2020
1	Fatigue 05/2020
1	Diarrhea 05/2020
1	Malaria 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2017
1	Inflammation (Inflammations) 01/2016
1	Pneumonia (Pneumonitis) 01/2014
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2014
1	Influenza in Birds (Avian Flu) 11/2010

Drug/Important Bio-Agent (IBA)

17	VaccinesIBA 04/2024 - 01/2016
7	Neutralizing AntibodiesIBA 04/2024 - 01/2016
7	CytokinesIBA 11/2022 - 01/2014
6	EpitopesIBA 01/2023 - 09/2015
4	AntigensIBA 12/2023 - 01/2019
4	Antiviral Agents (Antivirals)IBA 11/2020 - 11/2010
3	Inactivated VaccinesIBA 03/2024 - 12/2022
3	mRNA VaccinesIBA 03/2024 - 12/2022
3	Messenger RNA (mRNA)IBA 03/2024 - 01/2014
3	Peptides (Polypeptides)IBA 01/2020 - 01/2016
2	ProteomeIBA 01/2023 - 11/2022
2	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2022 - 01/2017
2	Interferon-betaIBA 01/2020 - 02/2010
2	GlycolipidsIBA 01/2020 - 11/2017
2	Granzymes (Granzyme)IBA 11/2018 - 01/2016
2	HLA-A Antigens (HLA-A)IBA 01/2018 - 04/2016
1	Proteins (Proteins, Gene)FDA Link 03/2024
1	Combined VaccinesIBA 03/2024
1	RQ3013 COVID-19 vaccineIBA 10/2023
1	ZF2001 COVID-19 vaccineIBA 10/2023
1	Immunodominant EpitopesIBA 01/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 12/2022
1	Immunoglobulin G (IgG)IBA 12/2022
1	Indicators and Reagents (Reagents)IBA 11/2022
1	RNA (Ribonucleic Acid)IBA 11/2022
1	Interleukin-17 (Interleukin 17)IBA 10/2022
1	Interferon-gamma (Interferon, gamma)IBA 10/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022
1	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2022
1	Interleukin-23 (Interleukin 23)IBA 01/2022
1	Interleukin-12 (IL 12)IBA 01/2022
1	Interleukin-13IBA 04/2021
1	HLA-DR Antigens (HLA-DR)IBA 01/2021
1	Neuraminidase (Sialidase)IBA 11/2020
1	Zanamivir (Relenza)FDA Link 11/2020
1	Oseltamivir (Tamiflu)FDA Link 11/2020
1	aminoxanideIBA 11/2020
1	fibrin fragment D (D-dimer)IBA 05/2020
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2020
1	RezafunginIBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018
1	Protein Subunit VaccinesIBA 11/2017
1	Chemokine CXCL10IBA 01/2017
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2016
1	HLA-B Antigens (HLA-B)IBA 04/2016
1	HLA-A*24:02 antigenIBA 04/2016
1	ChemokinesIBA 01/2016
1	Interleukin-18 (Interleukin 18)IBA 01/2016
1	InterferonsIBA 01/2014
1	Methylprednisolone FDA LinkGeneric 01/2014
1	Viral RNAIBA 11/2010

Therapy/Procedure

2	Immunotherapy 01/2018 - 01/2016
1	Artificial Respiration (Mechanical Ventilation) 05/2020
1	Mechanical Ventilators (Ventilator) 01/2014
1	Therapeutics 01/2014